These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11110033)

  • 1. Enhancement of the mydriatic response to tropicamide by bioadhesive polymers.
    Herrero-Vanrell R; Fernandez-Carballido A; Frutos G; Cadórniga R
    J Ocul Pharmacol Ther; 2000 Oct; 16(5):419-28. PubMed ID: 11110033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ophthalmic delivery systems based on drug-polymer-polymer ionic ternary interaction: in vitro and in vivo characterization.
    Sandri G; Bonferoni MC; Chetoni P; Rossi S; Ferrari F; Ronchi C; Caramella C
    Eur J Pharm Biopharm; 2006 Jan; 62(1):59-69. PubMed ID: 16162402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubilization of tropicamide by hydroxypropyl-beta-cyclodextrin and water-soluble polymers: in vitro/in vivo studies.
    Cappello B; Carmignani C; Iervolino M; Immacolata La Rotonda M; Fabrizio Saettone M
    Int J Pharm; 2001 Feb; 213(1-2):75-81. PubMed ID: 11165095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tropicamide 1% mydriatic effect: comparison between spray in closed eyes and eye drops in open eyes.
    Portes AJ; Barbosa AC; de Mello GL; Lopes MA; Cavalcanti RS
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):632-5. PubMed ID: 22775152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mydriatic efficacy of spray application and drop instillation of tropicamide 1%.
    Akman A; Aydin P
    Eye (Lond); 1999 Oct; 13 ( Pt 5)():653-5. PubMed ID: 10696320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucoadhesive Polymers Enhance Ocular Drug Delivery: Proof of Concept Study with 0.5% Tropicamide in Dogs.
    Arad D; Komoron S; Pe'er O; Sebbag L; Ofri R
    J Ocul Pharmacol Ther; 2022 Mar; 38(2):141-147. PubMed ID: 34962150
    [No Abstract]   [Full Text] [Related]  

  • 7. Pupillographic evaluation of the mydriatic effect of ibopamine solution.
    Gelmi C; Palazzuolo A; Lucchetti M; Trimarchi F
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):346-51. PubMed ID: 2777423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of mydriatic eye drops on the aberrometer predicted phoropter refraction].
    Taneri S; Stottmeister S; Krause K
    Klin Monbl Augenheilkd; 2010 Jan; 227(1):56-60. PubMed ID: 20091452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of tropicamide, homatropine, cyclopentolate, atropine and hyoscine as mydriatics in Angora goats.
    Whelan NC; Castillo-Alcala F; Lizarraga I
    N Z Vet J; 2011 Nov; 59(6):328-31. PubMed ID: 22040340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mydriatics release from solid and semi-solid ophthalmic formulations using different in vitro methods.
    Pescina S; Macaluso C; Gioia GA; Padula C; Santi P; Nicoli S
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1472-1479. PubMed ID: 28426341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and in vivo evaluation of ocular insert containing phenylephrine and tropicamide.
    Lee YC; Millard J; Negvesky GJ; Butrus SI; Yalkowsky SH
    Int J Pharm; 1999 May; 182(1):121-6. PubMed ID: 10332081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ophthalmic vehicles containing polymer-solubilized tropicamide: "in vitro/in vivo" evaluation.
    Carmignani C; Rossi S; Saettone MF; Burgalassi S
    Drug Dev Ind Pharm; 2002 Jan; 28(1):101-5. PubMed ID: 11858520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new preoperative ophthalmic solution.
    Hirowatari T; Tokuda K; Kamei Y; Miyazaki Y; Matsubara M
    Can J Ophthalmol; 2005 Feb; 40(1):58-62. PubMed ID: 15825531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does prior instillation of a topical anaesthetic alter the pupillary mydriasis produced by tropicamide (0.5%)?
    Haddad DE; Rosenfield M; Portello JK; Krumholz DM
    Ophthalmic Physiol Opt; 2007 May; 27(3):311-4. PubMed ID: 17470245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of mydriatic eye drops on wavefront sensing with the Zywave aberrometer.
    Taneri S; Oehler S; Azar DT
    J Refract Surg; 2011 Sep; 27(9):678-85. PubMed ID: 21446641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects on pupil size and accommodation of sympathetic and parasympatholytic agents.
    Paggiarino DA; Brancato LJ; Newton RE
    Ann Ophthalmol; 1993 Jul; 25(7):244-9, 253. PubMed ID: 8363290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in aqueous flare and cells after mydriasis.
    Oshika T; Kato S
    Jpn J Ophthalmol; 1989; 33(3):271-8. PubMed ID: 2796008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of three mydriatic drug regimens on pupil size in rhesus (Macaca mulatta) and African green monkeys (Chlorocebus aethiops).
    Merrill NL; Burge R
    J Med Primatol; 2007 Feb; 36(1):33-8. PubMed ID: 17359464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination solution for routine pupillary dilation.
    Krumholz DM; Portello JK; Rosenfield M; Rosenbaum JD
    Optometry; 2006 Jul; 77(7):350-3. PubMed ID: 16814239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adhesion of polyether-modified poly(acrylic acid) to mucin.
    Cleary J; Bromberg L; Magner E
    Langmuir; 2004 Oct; 20(22):9755-62. PubMed ID: 15491211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.